On 25 November 2025, Sanofi entered into a share purchase agreement to sell a 70% stake in the company operating its Lüleburgaz pharmaceutical manufacturing facility to Fareva, a world leader in industrial subcontracting for the pharmaceuticals, cosmetics, and industrial & household sectors. Sanofi will retain a 30% minority stake in the company.
The Lüleburgaz facility is one of Türkiye’s leading pharmaceutical manufacturing sites, with significant production capacity and export capabilities. The transaction is expected to close upon completion of customary regulatory approvals, including clearance from the Turkish Competition Authority.
Paksoy is pleased to announce that a team consisting of partner Stéphanie Beghe Sönmez, along with counsel Zeynep Toma and associates Selen Toma and Cansın Taner, is acting as counsel to Sanofi on this transaction.
Share
Related persons
You can contact us for detailed information.



Legal Information
This is for information purposes; it is not legal advice. As laws and their interpretation may change, please consult Turkish legal counsel to confirm the current position and obtain advice tailored to your circumstances before making any decision or taking action in relation to your matter in Türkiye. All rights reserved.
You May Be Interested In
19 October 2026
Merger clearance for Azimut’s acquisition of Yapı Kredi Portföy and landmark individual exemption for the 15-year distribution agreement
Two key Turkish Competition Board decisions were obtained in connection with Azimut’s acquisition of Yapı Kredi Portföy and the related…
15 October 2026
Mergermarket ranked us #1 in Türkiye by M&A deal value for 9M 2026
We are pleased to be recognised in the Mergermarket 2026-9M EMEA Legal Advisory Rankings, maintaining our #1 position by deal value in…
12 October 2026
Paksoy advises Turkven on its investment in Craftgate
On 8 October 2026, Turkven, one of the leading private equity firms focused on Türkiye, signed an agreement for the acquisition of shares…
6 October 2026
We celebrate 6 awards at the GBM Awards 2026
At the GBM Awards: CEE, Central Asia & Türkiye 2026, we celebrate 6 awards, recognising our strength in complex conventional and Islamic…
30 September 2026
Paksoy advises the Kocadağ Family on the sale of its 70% stake in Espressolab
On 23 September 2026, the Kocadağ Family entered into a share purchase agreement to sell their 70% stake in Espressolab, a leading local…
28 September 2026
Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark Litigation Europe Awards 2026
We are pleased to announce that our Founder & Senior Partner, Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark…
